triamcinolone has been researched along with Choroid Neovascularization in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 24 (88.89) | 29.6817 |
2010's | 1 (3.70) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Hashmi, U; Khalil, M; Riaz, R; Rukh Abbas, S | 1 |
Burton, BJ; Hughes, PW; Khatib, T | 1 |
Augustin, AJ; Offermann, I | 1 |
Cakir, M; Cekiç, O; Yilmaz, OF | 1 |
Attaran, M; Dueck, N; Gamulescu, MA; Schubert, K; Spital, G; Stroux, A; Thormann, S; Wachtlin, J; Wiechens, B | 1 |
Ho, CK; Tang, HH; Woo, CF; Yip, PP | 1 |
Kim, EY; Kim, JB; Kim, JW; Lew, HM | 1 |
Engelmann, K; Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU; Lappas, A | 1 |
Bonomo, PP; Cardillo, JA; Costa, RA; Farah, ME; Navajas, EV | 1 |
Kaiser, PK | 1 |
Behan, U; Hogan, A; Kilmartin, DJ | 1 |
Chan, WM; Lai, TY; Lam, DS; Liu, DT; Tong, JP; Wong, AL | 1 |
Lin, JM; Tsai, YY | 1 |
Bearelly, S; Cooney, MJ; Fackler, TK; Fekrat, S; Reddy, S; Stinnett, S | 1 |
Etter, J; Fekrat, S | 1 |
Rutishauser-Arnold, Y; Thölen, AM | 1 |
Braun, B; Hasler, P; Prünte, C; Schneider, U | 1 |
Gomez-Ulla, F; Luna, I; Marticorena, J; Romano, MR | 1 |
Ahmadieh, H; Azarmina, M; Dehghan, MH; Karkhaneh, R; Lashay, A; Moradian, S; Riazi-Esfahani, M; Soheilian, M; Taei, R | 1 |
Bakri, SJ; Ekdawi, NS | 1 |
Geitzenauer, W; Michels, S; Prager, F; Sacu, S; Schmidt-Erfurth, U; Varga, A; Weigert, G | 1 |
Hoerauf, H; Horn, W | 1 |
Ciulla, TA; Danis, RP; Martidis, A; Miller, DG; Moorthy, RS | 1 |
Ciulla, TA; Danis, RP; Pratt, L; Ranson, NT | 1 |
Penfold, PL | 1 |
4 review(s) available for triamcinolone and Choroid Neovascularization
Article | Year |
---|---|
[Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Topics: Alprostadil; Angiogenesis Inhibitors; Antioxidants; Choroidal Neovascularization; Clinical Trials as Topic; Combined Modality Therapy; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Triamcinolone; Vascular Endothelial Growth Factor A | 2008 |
[Pathogenesis of choroidal neovascularization. Old concepts, new questions].
Topics: Age Factors; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Cells, Cultured; Choroidal Neovascularization; Choroiditis; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Injuries; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Laser Therapy; Lymphokines; Macula Lutea; Macular Degeneration; Mice; Mice, Transgenic; Myopia; Photochemotherapy; Pigment Epithelium of Eye; Rats; Retinal Neovascularization; Risk Factors; Triamcinolone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Glucocorticoids; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Triamcinolone; Verteporfin; Visual Acuity | 2005 |
[Answered and unanswered questions regarding posterior segment complications in high myopia].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Humans; Myopia, Degenerative; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone; Vitrectomy | 2008 |
4 trial(s) available for triamcinolone and Choroid Neovascularization
Article | Year |
---|---|
[ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Exudates and Transudates; Female; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Treatment Outcome; Triamcinolone; Vitreous Body | 2009 |
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Disease Progression; Female; Glucocorticoids; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone; Verteporfin; Vision Disorders; Visual Acuity | 2006 |
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2007 |
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
19 other study(ies) available for triamcinolone and Choroid Neovascularization
Article | Year |
---|---|
Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases.
Topics: Animals; Chitosan; Choroidal Neovascularization; Coated Materials, Biocompatible; Delayed-Action Preparations; Disease Models, Animal; Humans; Liposomes; Rats; Triamcinolone | 2020 |
Unilateral choroidal granulomas complicated by choroidal neovascular membrane treated successfully with intravitreal triamcinolone in a patient with sarcoidosis.
Topics: Choroid; Choroidal Neovascularization; Female; Glucocorticoids; Granuloma; Humans; Intravitreal Injections; Middle Aged; Sarcoidosis; Triamcinolone; Uveal Diseases; Visual Acuity | 2014 |
Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Child; Choroidal Neovascularization; Corneal Dystrophies, Hereditary; Drug Therapy, Combination; Female; Humans; Tomography, Optical Coherence; Triamcinolone; Vitreous Body | 2009 |
Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2009 |
Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Diagnosis, Differential; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Middle Aged; Photochemotherapy; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Choroiditis; Coloring Agents; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Humans; Indocyanine Green; Injections, Intralesional; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Triamcinolone | 2003 |
Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation.
Topics: Adult; Anti-Infective Agents; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mycophenolic Acid; Photochemotherapy; Retrospective Studies; Tacrolimus; Treatment Outcome; Triamcinolone; Visual Acuity | 2005 |
[Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Germany; Glucocorticoids; Humans; Laser Coagulation; Macular Degeneration; Photochemotherapy; Porphyrins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnadienediols; Ranibizumab; Triamcinolone; Verteporfin | 2006 |
Intravitreal triamcinolone and PDT.
Topics: Choroidal Neovascularization; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids; Humans; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone; Verteporfin; Vitreous Body | 2006 |
Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone.
Topics: Age Factors; Aged; Choroidal Neovascularization; Female; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone; Verteporfin | 2006 |
Photodynamic therapy and intravitreal triamcinolone for extrafoveal choroidal neovascularization in neovascular age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
[Periocular sub-tenon triamcinolone acetonide injections for the treatment of retinal angiomatous proliferation (RAP) and occult choroidal neovascularisation].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Female; Hemangioma; Humans; Injections; Male; Retinal Neoplasms; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone | 2007 |
Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Female; Fundus Oculi; Humans; Middle Aged; Photochemotherapy; Retinal Diseases; Treatment Outcome; Triamcinolone | 2007 |
Repeated pseudoendophthalmitis after combined photodynamic therapy and intravitreal triamcinolone.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Endophthalmitis; Female; Glucocorticoids; Humans; Middle Aged; Photochemotherapy; Triamcinolone | 2007 |
Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Combinations; Female; Hemangioma; Humans; Retinal Neoplasms; Triamcinolone | 2008 |
[Intravitreal injections during anticoagulant treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Choroidal Neovascularization; Clopidogrel; Conjunctival Diseases; Humans; Injections; Intracranial Hemorrhages; Macular Degeneration; Phenprocoumon; Platelet Aggregation Inhibitors; Prospective Studies; Ranibizumab; Risk Factors; Ticlopidine; Triamcinolone; Vitreous Body; Vitreous Hemorrhage | 2008 |
Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.
Topics: Administration, Oral; Administration, Topical; Adult; Angiogenesis Inhibitors; Choroidal Neovascularization; Eye Infections, Fungal; Female; Fovea Centralis; Glucocorticoids; Histoplasmosis; Humans; Male; Middle Aged; Prednisone; Retrospective Studies; Time Factors; Triamcinolone; Visual Acuity | 1999 |
Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Humans; Laser Coagulation; Macular Degeneration; Recurrence; Triamcinolone | 2002 |
Intravitreal triamcinolone in recurrence of choroidal neovascularisation.
Topics: Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Choroidal Neovascularization; Humans; Macular Degeneration; Recurrence; Triamcinolone | 2002 |